Clearasil Rapid Rescue Deep Treatment Wash

Description

Clearasil® RAPID RESCUE DEEP TREATMENT WASH is a maximum strength acne medication formulated with salicylic acid. This treatment is designed to deliver visible results as quickly as 12 hours after application. The product begins to work instantly upon use. It is available in a dosage form of 6.78 fluid ounces (200 mL).

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The patient should begin by wetting the face. A sufficient amount of the product should be dispensed into the hands, where it should be lathered and gently massaged onto the face and neck, taking care to avoid the delicate eye area. After application, the product must be rinsed thoroughly with warm water, followed by patting the skin dry.

Initially, the product is to be applied once daily. Based on individual skin tolerance and as directed by a healthcare professional, the frequency of application may be gradually increased to two or three times daily. It is important to monitor for signs of excessive dryness or peeling; should these occur, the frequency of application should be reduced to once daily or every other day to mitigate these effects.

Contraindications

There are no specified contraindications for this product. However, healthcare professionals should advise patients to discontinue use and consult a physician if skin or eye irritation develops.

Contact with the eyes should be avoided; in the event of exposure, the eyes must be rinsed thoroughly with water. The risk of skin irritation and dryness may increase if used concurrently with other topical acne medications; therefore, it is recommended to use only one topical acne medication at a time if irritation occurs. Additionally, the product should be limited to application on the face and neck.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes. In the event of accidental exposure to the eyes, it is imperative to rinse thoroughly with water to mitigate potential irritation.

When utilizing this product, it is important to note that the likelihood of skin irritation and dryness may increase if used concurrently with other topical acne medications. Therefore, it is recommended that patients limit the use of topical acne treatments to one at a time to minimize the risk of adverse effects. Additionally, the application should be restricted to the face and neck areas only.

Patients should be instructed to discontinue use and consult a healthcare provider if any skin or eye irritation develops. It is crucial to keep this product out of reach of children. In cases of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is for external use only. Contact with the eyes should be avoided; in the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water.

Skin irritation and dryness are common adverse reactions, particularly if the product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients limit the use of topical acne treatments to one product at a time.

Patients should discontinue use and consult a healthcare professional if skin or eye irritation develops. Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Clearasil Rapid Rescue Deep Treatment Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach, as ingestion may require immediate medical attention or contact with a Poison Control Center.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily based on clinical need or physician guidance. In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day to maintain skin integrity and comfort.

Geriatric Use

There is no specific information regarding the use of Clearasil Rapid Rescue Deep Treatment Wash in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

There is no information available regarding the use of Clearasil Rapid Rescue Deep Treatment Wash during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits before recommending this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific contraindications. However, it is advisable to monitor breastfed infants for any potential effects, as no data on excretion in breast milk or effects on nursing infants are available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number: 1-866-25-CLEAR (1-866-252-5327).

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if they experience any skin or eye irritation. It is important to emphasize the need to avoid contact with the eyes; if the product does get into the eyes, patients should rinse thoroughly with water.

Additionally, healthcare providers should caution patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication simultaneously. If irritation does occur, patients should be advised to use only one topical acne medication at a time.

Finally, it is essential to limit the use of the product to the face and neck to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It should be stored in a cool, dry place to maintain its efficacy. Care should be taken to avoid freezing, as this may compromise the product's quality. Proper storage conditions are essential for ensuring the product remains effective throughout its shelf life.

Additional Clinical Information

The product is administered topically, with an initial recommendation of one application daily. Clinicians may advise patients to gradually increase the frequency to two or three times daily based on individual needs or medical guidance.

Patients should be counseled to avoid contact with the eyes; in the event of contact, they should rinse thoroughly with water. Concurrent use of other topical acne medications may increase the risk of skin irritation and dryness, so it is advisable to use only one topical acne treatment at a time if irritation occurs. The application should be limited to the face and neck, and patients are instructed to discontinue use and consult a doctor if skin or eye irritation develops. In case of ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Clearasil Rapid Rescue Deep Treatment Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)